The University of Minnesota College of Pharmacy, Department of Experimental and Clinical Pharmacology in collaboration with Genoa Healthcare is offering a two-year fellowship experience in psychopharmacology and pharmacogenomics for qualified applicants to develop advanced competencies in both clinical and translational research.
The objectives of the psychopharmacology and pharmacogenomics fellowship are as follows:
To develop competency and acquire clinical and computational research skills necessary for the conduct of clinical psychopharmacology and pharmacogenomics research.
To develop, initiate, and complete an independent research project, focused on pharmacy and clinic key metrics; supporting the addition of a pharmacy/pharmacist placement into a CMHC model. In addition, the fellow will participate in ongoing research studies at the University of Minnesota and Genoa Healthcare.
To obtain teaching experience in the didactic setting as well as in the clinical. The fellow will have the opportunity to engage in the co-precepting of pharmacy students, and to serve as lecturer and recitation facilitator in Doctor of Pharmacy or PhD program courses. Teaching experiences will be determined on an individual basis as related to past experiences and the individual's career goals and workload demands.
While in the program, the fellow is responsible for developing at least one research proposal for which they will act as the primary investigator. In developing the protocol(s), the fellow is responsible for the direction of at least one protocol involving human subjects (patient or healthy volunteers) which requires human subject investigation approval. Responsibilities include preparing the IRB application and human consent form as well as maintaining the appropriate study records. Clinical research methods training may include: various psychiatric rating scales for side effects and drug response, neuropsychological test administration, and opportunities to participate in neurophysiology assessments with collaborators. Fellows will also be trained in essential pharmacogenomics techniques including, but not limited to: genotyping, genetic data analysis, biospecimen acquisition, processing, banking and analyses and serum based biomarker analyses. Fellows will also participate in other ongoing studies. The fellow is responsible for the writing and submission of their research results to national and/or international venues as well as writing and submitting the results of their research to appropriate peer-reviewed journals for publication. It is expected that fellows will submit at least one small grant application during the fellowship period for which they will serve as primary investigator. Additionally, the fellow will be expected to write at least one review article for which they will serve as first author in addition to two first author research publications.
Clinical service will depend on the prior clinical experience of the applicant as well as their career goals. Clinical service will be used to facilitate the fellow’s research and to further develop clinical expertise. These activities will be conducted at Genoa Healthcare locations.
Applicants should possess a PharmD Degree. Completion of a postdoctoral residency is desired and eligibility for licensure in the State of Minnesota is required. A competitive salary and benefits package is offered.
About Clinical Psychopharmacology Postdoctoral Fellowship Program with an emphasis on Pharmacogenomics wit
Avella is a national specialty pharmacy dedicated to empowering patients, providers and other organizations across the entire healthcare continuum. We are invested in improving the health—and the lives—of the people we serve. We accomplish this goal by acting as expert clinicians, passionate advocates, committed healthcare partners and strategic innovators.
Avella provides a level of service and support that is rarely seen today. Our patient satisfaction rate is more than just a metric—it is a reflection of our commitment to caring for patients on their terms. We consistently hear from patients that we are “remarkable” “extraordinary” and “make a difference” in their lives. We earn these accolades by striving to respect each individual’s time, address their concerns about treatment and support their emotional well-being.
Yet we also employ the leading technology of tomorrow to complement, and not replace, our high-touch approach.
This includes mobile apps, a provider portal and smart pill bottles designed to improve care and create a better patient and provider experience.
Our staff collaborate with providers, drug manufacturers and payers to guide patients through every... step of their treatment— from securing prior authorization to product fulfillment and mid-therapy support. Our pharmacists can work with providers at a peer-to-peer level thanks to their deep disease state knowledge in specialties like oncology, pain and addiction management, infectious diseases and many other complex, chronic conditions.
Avella is actively improving access to care through our powerful specialty medications, including 50-plus limited distribution drugs, as well as compounded therapies created in our state-of-the-art clean rooms.